Clinical data | |
---|---|
Trade names | Endobil |
Other names | 3-[3-[2-[2-[2-[3-[(3-Carboxy-2,4,6-triiodophenyl)amino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-2,4,6-triiodobenzoic acid |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.045.875 |
Chemical and physical data | |
Formula | C26H26I6N2O10 |
Molar mass | 1287.925 g·mol−1 |
3D model ( JSmol) | |
|
Iodoxamic acid (trade name Endobil) is an organoiodine compound used as a radiocontrast agent. [1] It features both a high iodine content as well as several hydrophilic groups.
Clinical data | |
---|---|
Trade names | Endobil |
Other names | 3-[3-[2-[2-[2-[3-[(3-Carboxy-2,4,6-triiodophenyl)amino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-2,4,6-triiodobenzoic acid |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.045.875 |
Chemical and physical data | |
Formula | C26H26I6N2O10 |
Molar mass | 1287.925 g·mol−1 |
3D model ( JSmol) | |
|
Iodoxamic acid (trade name Endobil) is an organoiodine compound used as a radiocontrast agent. [1] It features both a high iodine content as well as several hydrophilic groups.